One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.4% in the afternoon session after positive Phase 3 ...

Merck and Moderna build a custom mRNA vaccine for each melanoma patient from tumor mutations. The strategy stumbles in cancers lacking enough targets ...

Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.

The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...

Personalized cancer vaccines are attracting growing attention as advances in mRNA technology open up new possibilities across oncology.

BioNTech's recent pipeline setback is a real cause of concern. But investors shouldn't panic.

Doctors discovered that Johnson had stage 2B triple-negative breast cancer, a rare and aggressive form. They treated her with ...

IntroductionIn recent years, mRNA technology, which gained sudden prominence with the COVID-19 vaccine, is now poised to ...